141 related articles for article (PubMed ID: 36470247)
1. Association of Substantia Nigra Degeneration with Poor Neurological Recovery in Basal Ganglia Infarctions.
Lee K; Lee H; Kim YD; Nam HS; Lee HS; Yoo J; Cho S; Heo JH
J Stroke; 2023 Jan; 25(1):169-172. PubMed ID: 36470247
[No Abstract] [Full Text] [Related]
2. Chemical neuroanatomy of the substantia nigra in the ovine brain.
Murray SJ; Black BL; Reid SJ; Rudiger SR; Simon Bawden C; Snell RG; Waldvogel HJ; Faull RLM
J Chem Neuroanat; 2019 Apr; 97():43-56. PubMed ID: 30664938
[TBL] [Abstract][Full Text] [Related]
3. Reaction of the substantia nigra to massive basal ganglia infarction.
Forno LS
Acta Neuropathol; 1983; 62(1-2):96-102. PubMed ID: 6686406
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging investigation of secondary degeneration of the mesencephalic substantia nigra after cerebral infarction.
Ohe Y; Uchino A; Horiuchi Y; Maruyama H; Deguchi I; Fukuoka T; Kato Y; Nagoya H; Dembo T; Tanahashi N
J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):58-65. PubMed ID: 21784662
[TBL] [Abstract][Full Text] [Related]
7. Basal ganglia lesions in 'Pick complex': a topographic neuropathological study of 19 autopsy cases.
Tsuchiya K; Ikeda K
Neuropathology; 2002 Dec; 22(4):323-36. PubMed ID: 12564774
[TBL] [Abstract][Full Text] [Related]
8. [Secondary degeneration of substantia nigra following massive basal ganglia infarction].
Ohara S; Kondo K; Kagoshima M; Yanagisawa N
Rinsho Shinkeigaku; 1989 Nov; 29(11):1352-6. PubMed ID: 2625020
[TBL] [Abstract][Full Text] [Related]
9. Substantia nigra control of basal ganglia nuclei.
Guatteo E; Cucchiaroni ML; Mercuri NB
J Neural Transm Suppl; 2009; (73):91-101. PubMed ID: 20411770
[TBL] [Abstract][Full Text] [Related]
10. Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration.
Quik M; Polonskaya Y; Gillespie A; K Lloyd G; Langston JW
Neuroscience; 2000; 100(1):63-72. PubMed ID: 10996459
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the basal ganglia, the pontine parabrachial region, and the trigeminal system in cat.
Schneider JS
Neuroscience; 1986 Oct; 19(2):411-25. PubMed ID: 3774149
[TBL] [Abstract][Full Text] [Related]
12. A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy.
Halliday GM; Hardman CD; Cordato NJ; Hely MA; Morris JG
Brain; 2000 Apr; 123 ( Pt 4)():724-32. PubMed ID: 10734004
[TBL] [Abstract][Full Text] [Related]
13. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain.
Wüllner U; Standaert DG; Testa CM; Penney JB; Young AB
Brain Res; 1997 Sep; 768(1-2):215-23. PubMed ID: 9369318
[TBL] [Abstract][Full Text] [Related]
15. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay.
Floor E; Wetzel MG
J Neurochem; 1998 Jan; 70(1):268-75. PubMed ID: 9422371
[TBL] [Abstract][Full Text] [Related]
16. Expression and localisation of CYP2D enzymes in rat basal ganglia.
Riedl AG; Watts PM; Edwards RJ; Schulz-Utermoehl T; Boobis AR; Jenner P; Marsden CD
Brain Res; 1999 Mar; 822(1-2):175-91. PubMed ID: 10082895
[TBL] [Abstract][Full Text] [Related]
17. Functional coupling between substantia nigra and basal ganglia homologues in amphibians.
Hoke KL; Ryan MJ; Wilczynski W
Behav Neurosci; 2007 Dec; 121(6):1393-9. PubMed ID: 18085893
[TBL] [Abstract][Full Text] [Related]
18. STRIATO-NIGRAL DEGENERATION.
ADAMS RD; VANBOGAERT L; VANDEREECKEN H
J Neuropathol Exp Neurol; 1964 Oct; 23():584-608. PubMed ID: 14219099
[No Abstract] [Full Text] [Related]
19. Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.
Jesse S; Kassubek J; Müller HP; Ludolph AC; Unrath A
BMC Neurol; 2012 Dec; 12():163. PubMed ID: 23273141
[TBL] [Abstract][Full Text] [Related]
20. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
